Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeshi Masuda

Showing results (241-250 of 298) with videos related to

Pageof 30
Sort By:
Research in Diagnostic and Interventional Imaging|July 30, 2024
Prediction model for patient prognosis in idiopathic pulmonary fibrosis using hybrid radiomics analysisDaisuke Kawahara, Takeshi Masuda, Riku Nishioka, et al.
Anti-Cancer Drugs|May 10, 2021
Gemcitabine maintenance therapy after gemcitabine and platinum drug chemotherapy for naive stage IIIB/IV squamous cell lung cancer: a phase II studyKosuke Hamai, Kazunori Fujitaka, Soichi Kitaguchi, et al.
Japanese Journal of Clinical Oncology|October 9, 2021
Potential benefits of volumetric modulated arc therapy to reduce the incidence of ≥ grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patientsNobuki Imano, Tomoki Kimura, Daisuke Kawahara, et al.
Science Advances|February 21, 2025
Mitochondrial translation regulates terminal erythroid differentiation by maintaining iron homeostasisTatsuya Morishima, Md Fakruddin, Yohei Kanamori, et al.
Haematologica|January 2, 2015
Role of the clathrin adaptor PICALM in normal hematopoiesis and polycythemia vera pathophysiologyYuichi Ishikawa, Manami Maeda, Mithun Pasham, et al.
The FEBS Journal|July 16, 2021
Acetylation of the influenza A virus polymerase subunit PA in the N-terminal domain positively regulates its endonuclease activityDai Hatakeyama, Masaki Shoji, Seiryo Ogata, et al.
Japanese Journal of Clinical Oncology|November 9, 2018
Impact of inflammatory marker levels one month after the first-line targeted therapy initiation on progression-free survival prediction in patients with metastatic clear cell renal cell carcinomaKeiichi Ito, Ayako Masunaga, Nobuyuki Tanaka, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 20, 2023
Clinical characteristics of extrapulmonary nontuberculous mycobacteria infections in comparison with pulmonary infections: A single-center, retrospective study in JapanKeitaro Omori, Hiroki Kitagawa, Kakuhiro Yamaguchi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 17, 2026
Stage- and Region-Dependent Proteomic Alterations in a Mouse Model of Creatine Transporter DeficiencyShingo Ito, Yumi Iwata, Tatsuki Uemura, et al.
European Urology Focus|July 21, 2017
External Validation of the MSKCC and IMDC Risk Models in Patients Treated with Targeted Therapy as a First-line and Subsequent Second-line Treatment: A Japanese Multi-institutional StudyNobuyuki Tanaka, Ryuichi Mizuno, Keiichi Ito, et al.
Pageof 30

Showing results (241-250 of 298) with videos related to

Sort By:
Pageof 30
Research in Diagnostic and Interventional Imaging|July 30, 2024
Prediction model for patient prognosis in idiopathic pulmonary fibrosis using hybrid radiomics analysisDaisuke Kawahara, Takeshi Masuda, Riku Nishioka, et al.
Anti-Cancer Drugs|May 10, 2021
Gemcitabine maintenance therapy after gemcitabine and platinum drug chemotherapy for naive stage IIIB/IV squamous cell lung cancer: a phase II studyKosuke Hamai, Kazunori Fujitaka, Soichi Kitaguchi, et al.
Japanese Journal of Clinical Oncology|October 9, 2021
Potential benefits of volumetric modulated arc therapy to reduce the incidence of ≥ grade 2 radiation pneumonitis in radiotherapy for locally advanced non-small cell lung cancer patientsNobuki Imano, Tomoki Kimura, Daisuke Kawahara, et al.
Science Advances|February 21, 2025
Mitochondrial translation regulates terminal erythroid differentiation by maintaining iron homeostasisTatsuya Morishima, Md Fakruddin, Yohei Kanamori, et al.
Haematologica|January 2, 2015
Role of the clathrin adaptor PICALM in normal hematopoiesis and polycythemia vera pathophysiologyYuichi Ishikawa, Manami Maeda, Mithun Pasham, et al.
The FEBS Journal|July 16, 2021
Acetylation of the influenza A virus polymerase subunit PA in the N-terminal domain positively regulates its endonuclease activityDai Hatakeyama, Masaki Shoji, Seiryo Ogata, et al.
Japanese Journal of Clinical Oncology|November 9, 2018
Impact of inflammatory marker levels one month after the first-line targeted therapy initiation on progression-free survival prediction in patients with metastatic clear cell renal cell carcinomaKeiichi Ito, Ayako Masunaga, Nobuyuki Tanaka, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 20, 2023
Clinical characteristics of extrapulmonary nontuberculous mycobacteria infections in comparison with pulmonary infections: A single-center, retrospective study in JapanKeitaro Omori, Hiroki Kitagawa, Kakuhiro Yamaguchi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 17, 2026
Stage- and Region-Dependent Proteomic Alterations in a Mouse Model of Creatine Transporter DeficiencyShingo Ito, Yumi Iwata, Tatsuki Uemura, et al.
European Urology Focus|July 21, 2017
External Validation of the MSKCC and IMDC Risk Models in Patients Treated with Targeted Therapy as a First-line and Subsequent Second-line Treatment: A Japanese Multi-institutional StudyNobuyuki Tanaka, Ryuichi Mizuno, Keiichi Ito, et al.
Pageof 30